QUANTUM GENOMICS Quantum Genomics Stock Deutsche Boerse AG
Equities
2QG
FR0011648971
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1164 EUR | +1.22% |
|
-0.51% | +32.27% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.34M 4.67M |
|---|---|---|---|---|---|
| Net income 2024 * | -3M -3.23M | Net income 2025 * | - | EV / Sales 2024 * | - |
| Net cash position 2024 * | 8.7M 9.36M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-1.38
x | P/E ratio 2025 * |
-
| Employees | 3 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.23% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +1.22% | ||
| 1 week | -0.51% | ||
| Current month | +5.82% | ||
| 1 month | +23.83% | ||
| 3 months | +17.58% | ||
| 6 months | +53.36% | ||
| Current year | +32.27% |
1 week
0.10
0.12
1 month
0.090.12
Current year
0.090.13
1 year
0.070.19
3 years
0.076.11
5 years
0.076.11
10 years
0.076.11
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | - | |
Lionel Ségard
FOU | Founder | 56 | 05-12-22 |
Benoît Gueugnon
DFI | Director of Finance/CFO | - | 18-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lionel Ségard
FOU | Founder | 56 | 05-12-22 |
François Pelen
BRD | Director/Board Member | 67 | - |
| Chief Executive Officer | 63 | - |
| Date | Price | Change |
|---|---|---|
| 24-05-03 | 0.1164 | +1.22% |
| 24-05-02 | 0.115 | +4.55% |
| 24-04-30 | 0.11 | 0.00% |
| 24-04-29 | 0.11 | -5.98% |
Delayed Quote Deutsche Boerse AG, May 03, 2024 at 03:15 am EDT
More quotes
Quantum Genomics is a biotechnology company that specializes in the research and development of drugs for the treatment of cardiovascular diseases such as high blood pressure and heart failure.
All sales are abroad.
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.1244
EUR
Average target price
0.1
EUR
Spread / Average Target
-19.61%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +25.69% | 47.9B | |
| +46.90% | 41.42B | |
| -3.46% | 40.7B | |
| -6.20% | 28.92B | |
| +9.17% | 25.55B | |
| -20.42% | 19.27B | |
| +0.17% | 12.15B | |
| +28.07% | 12.14B | |
| -1.24% | 11.99B |
- Stock Market
- Equities
- ALQGC Stock
- 2QG Stock
